KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Capital Employed: 2010-2025

Historic Return on Capital Employed for Emergent BioSolutions (EBS) over the last 16 years, with Sep 2025 value amounting to 0.09%.

  • Emergent BioSolutions' Return on Capital Employed rose 20.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 20.00%. This contributed to the annual value of 0.08% for FY2024, which is 32.00% up from last year.
  • Emergent BioSolutions' Return on Capital Employed amounted to 0.09% in Q3 2025, which was up 10.58% from 0.08% recorded in Q2 2025.
  • Emergent BioSolutions' 5-year Return on Capital Employed high stood at 0.21% for Q1 2021, and its period low was 0.60% during Q4 2023.
  • Moreover, its 3-year median value for Return on Capital Employed was 0.18% (2023), whereas its average is 0.24%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by 61bps in 2023, then skyrocketed by 52bps in 2024.
  • MRQ analysis of 5 years shows Emergent BioSolutions' Return on Capital Employed stood at 0.13% in 2021, then crashed by 170bps to 0.09% in 2022, then plummeted by 538bps to 0.60% in 2023, then soared by 86bps to 0.09% in 2024, then skyrocketed by 206bps to 0.09% in 2025.
  • Its last three reported values are 0.09% in Q3 2025, 0.08% for Q2 2025, and 0.08% during Q1 2025.